Talis Biomedical Corporation Earnings Per Share, Basic and Diluted
Talis Biomedical Corporation reported Earnings Per Share, Basic and Diluted of -$1.01 per share for the 3-month period ending 2022-06-30, per its 10-Q filed 2022-08-02.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2022-08-02
- Talis Biomedical Corporation earnings per share, basic and diluted for the quarter ending 2022-06-30 was -$1.01.
- Talis Biomedical Corporation earnings per share, basic and diluted for the quarter ending 2022-03-31 was -$1.25.
- Talis Biomedical Corporation earnings per share, basic and diluted for the quarter ending 2021-12-31 was -$0.89.
- Talis Biomedical Corporation earnings per share, basic and diluted for the quarter ending 2021-09-30 was -$1.49.
- Talis Biomedical Corporation earnings per share, basic and diluted for fiscal 2021 was -$8.48.
- Talis Biomedical Corporation earnings per share, basic and diluted for fiscal 2020 was -$42.98.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2022-06-30 | -$1.01 10-Q · filed 2022-08-02 | -$2.26 10-Q · filed 2022-08-02 | -$3.12 derived: net income ÷ weighted average shares · filed 2023-11-14 | -$4.57 derived: net income ÷ weighted average shares · filed 2023-11-14 |
| 2022-03-31 | -$1.25 10-Q · filed 2022-05-10 | -$2.10 derived: net income ÷ weighted average shares · filed 2023-11-14 | -$3.55 derived: net income ÷ weighted average shares · filed 2023-11-14 | -$5.97 derived: net income ÷ weighted average shares · filed 2023-11-14 |
| 2021-12-31 | -$0.89 derived: net income ÷ weighted average shares · filed 2023-03-22 | -$2.31 derived: net income ÷ weighted average shares · filed 2023-03-22 | -$4.71 derived: net income ÷ weighted average shares · filed 2023-03-22 | -$8.48 10-K · filed 2022-03-15 |
| 2021-09-30 | -$1.49 10-Q · filed 2021-11-16 | -$4.00 derived: net income ÷ weighted average shares · filed 2022-11-03 | -$8.41 10-Q · filed 2021-11-16 | -$12.45 derived: net income ÷ weighted average shares · filed 2022-11-03 |
| 2021-06-30 | -$2.51 10-Q · filed 2022-08-02 | -$6.44 10-Q · filed 2022-08-02 | -$12.41 derived: net income ÷ weighted average shares · filed 2022-11-03 | -$18.48 derived: net income ÷ weighted average shares · filed 2022-11-03 |
| 2021-03-31 | -$4.61 10-Q · filed 2022-05-10 | -$13.74 derived: net income ÷ weighted average shares · filed 2022-11-03 | -$23.19 derived: net income ÷ weighted average shares · filed 2022-11-03 | -$29.63 derived: net income ÷ weighted average shares · filed 2022-11-03 |
| 2020-12-31 | -$20.79 derived: net income ÷ weighted average shares · filed 2022-03-15 | -$34.70 derived: net income ÷ weighted average shares · filed 2022-03-15 | -$39.48 derived: net income ÷ weighted average shares · filed 2022-03-15 | -$42.98 10-K · filed 2022-03-15 |
| 2020-09-30 | -$13.90 10-Q · filed 2021-11-16 | -$18.66 derived: net income ÷ weighted average shares · filed 2021-11-16 | -$22.15 10-Q · filed 2021-11-16 | |
| 2020-06-30 | -$4.75 10-Q · filed 2021-08-10 | -$8.23 10-Q · filed 2021-08-10 | ||
| 2020-03-31 | -$3.49 10-Q · filed 2021-05-13 |